Wipi1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Wipi1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
WIPI1 (WD repeat domain, phosphoinositide interacting 1) is a PI3P-binding protein that localizes to developing autophagosomes. As a member of the PROPPIN family (beta-propellers that bind phosphoinositides), WIPI1 is essential for autophagosome nucleation and expansion. WIPI1 functions as a critical scaffold protein in the early stages of autophagy, coordinating the recruitment of downstream autophagy-related proteins to the expanding phagophore membrane. The protein is highly conserved across eukaryotes and is expressed ubiquitously in human tissues, with particularly high expression in brain regions involved in neurodegenerative processes.
Structure
WIPI1 contains several structural features that enable its function in autophagy:
Seven WD40 repeat beta-propeller domains: These seven-bladed beta-propeller structures form a conserved protein-protein interaction platform that facilitates binding to multiple autophagy-related proteins
PI3P-binding site: The wedge-like structure at the N-terminus specifically recognizes phosphatidylinositol 3-phosphate (PI3P) on nascent autophagosomal membranes
LC3-interacting region (LIR): WIPI1 contains a canonical LIR motif (positions 231-234: DDVTI) that enables binding to LC3/GABARAP family proteins
FRRG motif: The characteristic FRRG sequence in loop 7 of blade 7 is essential for phosphoinositide binding
Dimerization interface: WIPI1 can form homodimers, which may be important for its scaffolding function
Molecular Function
Autophagosome Biogenesis
WIPI1 plays multiple roles in autophagosome formation:
PI3P effector: WIPI1 binds to PI3P-rich membranes at the site of autophagosome nucleation (omegasomes)
The study of Wipi1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Proikas-Cezanne T et al, (2015) WIPI proteins: Essential PtdIns3P effectors for the autophagy cascade (2015)](https://pubmed.ncbi.nlm.nih.gov/26607380/)
[Bakula D et al, (2017) WIPI3 and WIPI4 beta-propellers are scaffolds for LKB1-AMPK-TSC signaling circuits in the control of autophagy (2017)](https://pubmed.ncbi.nlm.nih.gov/28561067/)
[Mercer TJ et al, (2018) Lipid trafficking and the role of WIPI proteins in autophagy (2018)](https://pubmed.ncbi.nlm.nih.gov/30017542/)
[Pfisterer SG et al, (2021) WIPI proteins in autophagy and disease (2021)](https://pubmed.ncbi.nlm.nih.gov/33484368/)
[Tang J et al, (2019) WIPI1 regulates the formation of autophagosomes and is a therapeutic target in Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31152356/)
[Zhen Y et al, (2020) ATG2 proteins are required for autophagosome recruitment (2020)](https://pubmed.ncbi.nlm.nih.gov/33326792/)
[Busch F et al, (2022) The structure of the WIPI1-ATG2 complex reveals the molecular basis of autophagy initiation (2022)](https://pubmed.ncbi.nlm.nih.gov/35654942/)
[Zhao YG et al, (2023) Autophagy biogenesis and machinery (2023)](https://pubmed.ncbi.nlm.nih.gov/36539568/)